Forward-thinking UK companies are adapting their business models, products and processes to gain traction in overseas markets
30.01.13 Life Sciences sector in Portugal
While the Portuguese National Healthcare System (SNS) faces major restructuring, opportunities arise for suppliers of cost saving solutions, with local players very open to international partnerships.
The UK is a global leader in stratified medicine, putting the patient first as well as opening up the rich data and research resources of the National Health Service (NHS)
Howard is a highly-qualified healthcare management professional with over 30 years’ experience of public and private sector healthcare throughout the UK and in more than 65 countries worldwide, advising on health services management and strategic health sector reform.
The UK Government is committed to creating the ideal business environment to ensure overseas companies continue to invest in the UK life science industry.
The UK is committed to making clinical study start-up more efficient, introducing the Health Research Authority to streamline approvals for clinical research and new performance metrics for patient recruitment.
The UK Government is committed to ensuring there is a step change in the research activities and adoption of new products into the NHS.
UK science is informed by real world data and information, from bioresources to anonymised patient records, clinical practice, and outcomes data.
The UK has a heritage of life science discovery that has transformed scientific knowledge and continues to unlock clinical and commercial opportunities.
With the increasing cost, risk and complexity of research and development, it has become increasingly challenging for life sciences companies to commercialise medical innovation.